These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 33745422)

  • 21. Nanomedicine Strategies to Enhance Tumor Drug Penetration in Pancreatic Cancer.
    Lu T; Prakash J
    Int J Nanomedicine; 2021; 16():6313-6328. PubMed ID: 34552327
    [TBL] [Abstract][Full Text] [Related]  

  • 22. T-cell programming in pancreatic adenocarcinoma: a review.
    Seo YD; Pillarisetty VG
    Cancer Gene Ther; 2017 Mar; 24(3):106-113. PubMed ID: 27910859
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The new era of pancreatic cancer treatment: Application of nanotechnology breaking through bottlenecks.
    Luo W; Zhang T
    Cancer Lett; 2024 Jul; 594():216979. PubMed ID: 38795762
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical study of genomic drivers in pancreatic ductal adenocarcinoma.
    Barrett MT; Deiotte R; Lenkiewicz E; Malasi S; Holley T; Evers L; Posner RG; Jones T; Han H; Sausen M; Velculescu VE; Drebin J; O'Dwyer P; Jameson G; Ramanathan RK; Von Hoff DD
    Br J Cancer; 2017 Aug; 117(4):572-582. PubMed ID: 28720843
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pancreatic stellate cells form a niche for cancer stem cells and promote their self-renewal and invasiveness.
    Lonardo E; Frias-Aldeguer J; Hermann PC; Heeschen C
    Cell Cycle; 2012 Apr; 11(7):1282-90. PubMed ID: 22421149
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Paradoxical Web of Pancreatic Cancer Tumor Microenvironment.
    Lafaro KJ; Melstrom LG
    Am J Pathol; 2019 Jan; 189(1):44-57. PubMed ID: 30558722
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A tunable delivery platform to provide local chemotherapy for pancreatic ductal adenocarcinoma.
    Indolfi L; Ligorio M; Ting DT; Xega K; Tzafriri AR; Bersani F; Aceto N; Thapar V; Fuchs BC; Deshpande V; Baker AB; Ferrone CR; Haber DA; Langer R; Clark JW; Edelman ER
    Biomaterials; 2016 Jul; 93():71-82. PubMed ID: 27082874
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel targets in pancreatic cancer research.
    Kozak G; Blanco FF; Brody JR
    Semin Oncol; 2015 Feb; 42(1):177-87. PubMed ID: 25726061
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ultrasound-Guided Orthotopic Implantation of Murine Pancreatic Ductal Adenocarcinoma.
    Hay CA; Sor R; Flowers AJ; Clendenin C; Byrne KT
    J Vis Exp; 2019 Nov; (153):. PubMed ID: 31814615
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biomimetic nanoparticles delivered hedgehog pathway inhibitor to modify tumour microenvironment and improved chemotherapy for pancreatic carcinoma.
    Jiang T; Zhang B; Zhang L; Wu X; Li H; Shen S; Luo Z; Liu X; Hu Y; Pang Z; Jiang X
    Artif Cells Nanomed Biotechnol; 2018; 46(sup1):1088-1101. PubMed ID: 29484905
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A mechanopharmacology approach to overcome chemoresistance in pancreatic cancer.
    Coppola S; Carnevale I; Danen EHJ; Peters GJ; Schmidt T; Assaraf YG; Giovannetti E
    Drug Resist Updat; 2017 Mar; 31():43-51. PubMed ID: 28867243
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Therapeutic effects of an anti-Myc drug on mouse pancreatic cancer.
    Stellas D; Szabolcs M; Koul S; Li Z; Polyzos A; Anagnostopoulos C; Cournia Z; Tamvakopoulos C; Klinakis A; Efstratiadis A
    J Natl Cancer Inst; 2014 Dec; 106(12):. PubMed ID: 25306215
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tumour microenvironment and heterotypic interactions in pancreatic cancer.
    Velasco RM; García AG; Sánchez PJ; Sellart IM; Sánchez-Arévalo Lobo VJ
    J Physiol Biochem; 2023 Feb; 79(1):179-192. PubMed ID: 35102531
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pancreatic ductal adenocarcinoma progression is restrained by stromal matrix.
    Jiang H; Torphy RJ; Steiger K; Hongo H; Ritchie AJ; Kriegsmann M; Horst D; Umetsu SE; Joseph NM; McGregor K; Pishvaian MJ; Blais EM; Lu B; Li M; Hollingsworth M; Stashko C; Volmar K; Yeh JJ; Weaver VM; Wang ZJ; Tempero MA; Weichert W; Collisson EA
    J Clin Invest; 2020 Sep; 130(9):4704-4709. PubMed ID: 32749238
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Promising new therapies in advanced pancreatic adenocarcinomas.
    Kundranda M; Kachaamy T
    Future Oncol; 2014 Dec; 10(16):2629-41. PubMed ID: 25531049
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pancreatic cancer: Stroma and its current and emerging targeted therapies.
    Kota J; Hancock J; Kwon J; Korc M
    Cancer Lett; 2017 Apr; 391():38-49. PubMed ID: 28093284
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recapitulation of complex transport and action of drugs at the tumor microenvironment using tumor-microenvironment-on-chip.
    Han B; Qu C; Park K; Konieczny SF; Korc M
    Cancer Lett; 2016 Sep; 380(1):319-29. PubMed ID: 26688098
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Targeted Therapies for Pancreatic Cancer and Hurdles Ahead.
    Aslan M; Shahbazi R; Ulubayram K; Ozpolat B
    Anticancer Res; 2018 Dec; 38(12):6591-6606. PubMed ID: 30504367
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rational combinations of immunotherapy for pancreatic ductal adenocarcinoma.
    Blair AB; Zheng L
    Chin Clin Oncol; 2017 Jun; 6(3):31. PubMed ID: 28705008
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pathophysiological role of microRNA-29 in pancreatic cancer stroma.
    Kwon JJ; Nabinger SC; Vega Z; Sahu SS; Alluri RK; Abdul-Sater Z; Yu Z; Gore J; Nalepa G; Saxena R; Korc M; Kota J
    Sci Rep; 2015 Jun; 5():11450. PubMed ID: 26095125
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.